Arbutus Biopharma
Christine Espiritu currently works as a Sr. Scientist at Arbutus Biopharma Corporation and has extensive experience in HBV drug discovery. Prior to their current role, Christine has held positions at various prestigious organizations such as Janssen Pharmaceutical R&D, Novira Therapeutics, and Gilead Sciences, where Christine has played key roles in drug development and research. Christine's educational background includes a Master's degree in Biology with a focus on Recombinant DNA Technology from New York University and a Bachelor's degree in Biochemistry from the University of California, Los Angeles.
This person is not in any offices
Arbutus Biopharma
2 followers
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).